A detailed history of Citigroup Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Citigroup Inc holds 484,350 shares of EW stock, worth $31.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
484,350
Previous 350,405 38.23%
Holding current value
$31.7 Million
Previous $33.5 Million 33.61%
% of portfolio
0.03%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$84.3 - $94.31 $11.3 Million - $12.6 Million
133,945 Added 38.23%
484,350 $44.7 Million
Q1 2024

May 10, 2024

SELL
$72.54 - $95.56 $1.73 Million - $2.28 Million
-23,853 Reduced 6.37%
350,405 $33.5 Million
Q4 2023

Feb 09, 2024

SELL
$61.71 - $77.76 $3.16 Million - $3.99 Million
-51,283 Reduced 12.05%
374,258 $28.5 Million
Q3 2023

Nov 09, 2023

SELL
$69.28 - $93.38 $4.87 Million - $6.56 Million
-70,288 Reduced 14.18%
425,541 $29.5 Million
Q2 2023

Aug 10, 2023

SELL
$81.41 - $94.33 $2.39 Million - $2.77 Million
-29,362 Reduced 5.59%
495,829 $46.8 Million
Q1 2023

May 11, 2023

BUY
$74.26 - $84.51 $6.89 Million - $7.84 Million
92,745 Added 21.45%
525,191 $43.4 Million
Q4 2022

Feb 09, 2023

SELL
$68.3 - $87.44 $1.27 Million - $1.62 Million
-18,566 Reduced 4.12%
432,446 $32.3 Million
Q3 2022

Nov 10, 2022

BUY
$82.37 - $107.29 $6.83 Million - $8.9 Million
82,945 Added 22.54%
451,012 $37.3 Million
Q2 2022

Aug 10, 2022

BUY
$86.5 - $128.27 $3.63 Million - $5.39 Million
41,990 Added 12.88%
368,067 $35 Million
Q1 2022

May 12, 2022

SELL
$101.96 - $128.34 $3.27 Million - $4.12 Million
-32,112 Reduced 8.97%
326,077 $38.4 Million
Q4 2021

Feb 10, 2022

SELL
$106.37 - $130.68 $1.45 Million - $1.79 Million
-13,677 Reduced 3.68%
358,189 $46.4 Million
Q3 2021

Nov 10, 2021

BUY
$102.91 - $122.75 $38.3 Million - $45.6 Million
371,866 New
371,866 $42.1 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.